Browse Items (2 total)
- Tags: Aman MG
Risperidone in children with autism and serious behavioral problems
Tags: 2002, Adolescent, Aman MG, Antipsychotic Agents/administration & dosage/adverse effects/therapeutic use, Arnold LE, Autistic Disorder/drug therapy/psychology, Backlog, Carroll D, Child, Child Behavior/drug effects, Comparative Study, Cronin P, Davies M, Double-Blind Method, Female, Ghuman J, Gonzalez NM, Grados M, Hollway J, Hong D, Humans, Journal Article, Koenig K, Kohn A, Lancor A, Lindsay R, Male, Martin A, McCracken JT, McDougle CJ, McGough J, McMahon D, Nash P, Non-U.S. Gov't, P.H.S., Posey D, Preschool, Research Support, Research Units on Pediatric Psychopharmacology (RUPP) Autism Network, Risperidone/administration & dosage/adverse effects/therapeutic use, Ritz L, Robinson J, Scahill L, Shah B, Swiezy N, The New England Journal Of Medicine, Tierney E, Treatment Outcome, U.S. Gov't, Vitiello B, Volkmar F
Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities
Tags: 1993, Adrenergic beta-Antagonists/tu [Therapeutic Use], Aman MG, Annals Of Clinical Psychiatry : Official Journal Of The American Academy Of Clinical Psychiatrists, Anti-Anxiety Agents/tu [Therapeutic Use], Antidepressive Agents/cl [Classification], Antidepressive Agents/tu [Therapeutic Use], Antipsychotic Agents/ad [Administration & Dosage], Antipsychotic Agents/pd [Pharmacology], Antipsychotic Agents/tu [Therapeutic Use], Backlog, Comparative Study, Dopamine/me [Metabolism], Female, Human, Journal Article, Lithium Carbonate/tu [Therapeutic Use], Male, Mental Retardation/co [Complications], Mental Retardation/di [Diagnosis], Naloxone/tu [Therapeutic Use], Naltrexone/tu [Therapeutic Use], P.H.S., Receptors, Self-Injurious Behavior/co [Complications], Self-Injurious Behavior/dt [Drug Therapy], Support, Treatment Outcome, U.S. Gov't